Dyne Therapeutics Inc (DYN) Stock Analysis

Dyne Therapeutics Inc (DYN) is a publicly traded company in the HEALTHCARE sector. It trades at $17.24, carries a market capitalization of $3.08B. This page summarizes the public market data, fundamentals, and frequently asked questions for DYN, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Dyne Therapeutics Inc currently has a Bullish sentiment score of 0.34.

About Dyne Therapeutics Inc

Dyne Therapeutics, Inc. is a cutting-edge biotechnology firm headquartered in Waltham, Massachusetts, focused on transforming the treatment landscape for genetically-driven muscle diseases. Utilizing its proprietary muscle-targeted delivery platform, the company is advancing a diverse pipeline of innovative therapeutic candidates designed to meet critical unmet medical needs in this specialized sector. With a commitment to developing impactful therapies, Dyne Therapeutics is poised to improve...

GNG Research Analysis

GNG Research scores Dyne Therapeutics Inc (DYN) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for DYN.

Frequently Asked Questions

Does DYN pay dividends?

Dyne Therapeutics Inc (DYN) does not currently pay a regular dividend.

What is DYN's market cap?

Dyne Therapeutics Inc (DYN) has a market capitalization of $3.08B with a current stock price of $17.24.